Effects of Adrenocorticotropic Hormone (ACTHAR Gel) on Recovery From Cognitive Relapses in Multiple Sclerosis

Trial Profile

Effects of Adrenocorticotropic Hormone (ACTHAR Gel) on Recovery From Cognitive Relapses in Multiple Sclerosis

Recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Apr 2017

At a glance

  • Drugs Corticotropin (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Apr 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
    • 24 Apr 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
    • 13 Oct 2016 Planned end date changed from 1 Aug 2016 to 1 Dec 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top